跳至主要内容
临床试验/CTRI/2015/12/006443
CTRI/2015/12/006443进行中(未招募)4 期

A randomized controlled trial of topical Mupirocin versus Mupirocin with Sucralfate combination in chronic skin ulcers.

Strassenburg Pharmaceuticals Ltd0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either sex of age > 18 years
  • Patients having grade 1 and grade 2 ulcer according to Wagner grading system.
  • Ulcer of duration > 4 weeks.
  • Wagner grading system
  • AGrade 1Superficial ulcer
  • BGrade 2Ulcer extension
  • 1. Involves ligament, tendon, joint capsule or fascia
  • 2. No abscess or osteomyelitis
  • CGrade 3Deep ulcer with abscess or osteomyelitis
  • DGrade 4Gangrene
  • EGrade 5Extensive gangrene

排除标准

  • Female patients who are pregnant or breast-feeding.
  • Patients having ulcer grade >2 according to Wagner grading system
  • Ulcer of duration > 6 months.Patients diagnosed to have decubitus ulcer.
  • Patients diagnosed to have ulceration due to malignancy.
  • Patients who have used formulations containing mupirocin or sucralfate for their ulcer within the last 4 weeks.
  • Patients with history of hypersensitivity to formulations containing mupirocin or sucralfate.
  • Patients suffering from debilitating chronic diseases including frankly uncontrolled diabetes and advanced malignancy.
  • Patients suffering from frankly immunocompromising disorders such as HIV/AIDS.
  • Patients on systemic antimicrobials, corticosteroids or any other medication known to influence wound healing currently or within last 4 weeks.
  • Patients suffering from alcoholism, substance abuse or psychiatric disorders that are liable to make them unreliable trial subjects.
  • Patients without adequate caregiver support at home who can supervise application of medication.
  • Any other condition which, in the opinion of the investigators, is likely to substantially increase the risk of non-adherence or the possibility of confounding of results.

研究者

发起方
Strassenburg Pharmaceuticals Ltd

相似试验